Advisor Managed Portfolios (OPTZ)
管理公司 · XNAS · 系列 S000084701 · 在 SEC EDGAR 上查看 ↗
$46.29
截至 2026年8月21日
▲ +0.24 (+0.53%)
1日变动
$32.77 – $48.42
52周范围
该基金的持仓数据尚未提供。
本页内容
OPTZ 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
业绩 截至 2026年8月20日
| 期间 | 价格回报 | 总回报 |
|---|---|---|
| 1M | ▲ +23.40% | — |
| 3M | ▲ +23.40% | — |
| 6M | ▲ +18.61% | — |
| 年初至今 | ▲ +27.75% | — |
| 1Y | ▲ +39.57% | — |
| 3Y | — | — |
| 5Y | — | — |
| 最大 自 2024年4月23日 起 | ▲ +81.66% | — |
- 1年波动率
- 36.59%
- 3年波动率
- —
- 3年最大回撤
- —
- 3年Beta值
- —
- 1年夏普比率*
- 1.64
在收集完该基金的股息历史后，将显示总回报率——仅显示价格回报率会产生误导性的重复。回报率未与指数进行基准比较。 * 夏普比率按0%无风险利率计算。
基金流向（SEC报告）
- 上个月（三月 2026）
- +$3.9M
- 截至三月 2026的季度
- +$9.2M
- 过去12个月
- +$8.3M
四月 2025 – 三月 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
完整构成 338 持仓
| 名称 | CUSIP | 价值 | % | 余额 | 类别 | 国家 |
|---|---|---|---|---|---|---|
| Elevance Health Inc | 036752103 | $448K | 0.21 | 1530 | EC | US |
| S&P Global Inc | 78409V104 | $447K | 0.21 | 1052 | EC | US |
| Amylyx Pharmaceuticals Inc | 03237H101 | $445K | 0.21 | 32001 | EC | US |
| Trupanion Inc | 898202106 | $445K | 0.21 | 17360 | EC | US |
| Krystal Biotech Inc | 501147102 | $442K | 0.21 | 1710 | EC | US |
| Corpay Inc | 219948106 | $441K | 0.21 | 1515 | EC | US |
| Moody's Corp | 615369105 | $440K | 0.21 | 1009 | EC | US |
| Labcorp Holdings Inc | 504922105 | $438K | 0.21 | 1643 | EC | US |
| Globus Medical Inc | 379577208 | $438K | 0.21 | 5085 | EC | US |
| Jack Henry & Associates Inc | 426281101 | $438K | 0.21 | 2772 | EC | US |
| ArriVent Biopharma Inc | 04272N102 | $436K | 0.21 | 18916 | EC | US |
| WEX Inc | 96208T104 | $436K | 0.21 | 2850 | EC | US |
| Repligen Corp | 759916109 | $435K | 0.21 | 3693 | EC | US |
| Cigna Group/The | 125523100 | $435K | 0.21 | 1631 | EC | US |
| Incyte Corp | 45337C102 | $435K | 0.21 | 4620 | EC | US |
| Thermo Fisher Scientific Inc | 883556102 | $434K | 0.21 | 883 | EC | US |
| Fidelity National Information | 31620M106 | $434K | 0.21 | 9252 | EC | US |
| Wingstop Inc | 974155103 | $433K | 0.21 | 2796 | EC | US |
| Vertex Pharmaceuticals Inc | 92532F100 | $433K | 0.21 | 970 | EC | US |
| Sinclair Inc | 829242106 | $433K | 0.21 | 33469 | EC | US |
| MBX Biosciences Inc | 55287L101 | $433K | 0.21 | 14508 | EC | US |
| IQVIA Holdings Inc | 46266C105 | $433K | 0.21 | 2539 | EC | US |
| Cardinal Health Inc | 14149Y108 | $430K | 0.21 | 2035 | EC | US |
| Penumbra Inc | 70975L107 | $430K | 0.21 | 1308 | EC | US |
| Gilead Sciences Inc | 375558103 | $429K | 0.21 | 3079 | EC | US |
| Compass Therapeutics Inc | 20454B104 | $426K | 0.20 | 80439 | EC | US |
| STERIS PLC | — | $425K | 0.20 | 1922 | EC | US |
| First American Financial Corp | 31847R102 | $425K | 0.20 | 7047 | EC | US |
| MarketAxess Holdings Inc | 57060D108 | $422K | 0.20 | 2559 | EC | US |
| Amgen Inc | 031162100 | $422K | 0.20 | 1199 | EC | US |
| Stagwell Inc | 85256A109 | $422K | 0.20 | 67037 | EC | US |
| Indivior Pharmaceuticals Inc | 45579U109 | $419K | 0.20 | 13734 | EC | US |
| Becton Dickinson & Co | 075887109 | $417K | 0.20 | 2652 | EC | US |
| Solventum Corp | 83444M101 | $417K | 0.20 | 6385 | EC | US |
| Intuitive Surgical Inc | 46120E602 | $417K | 0.20 | 904 | EC | US |
| McKesson Corp | 58155Q103 | $416K | 0.20 | 481 | EC | US |
| Universal Health Services Inc | 913903100 | $412K | 0.20 | 2300 | EC | US |
| Eli Lilly & Co | 532457108 | $411K | 0.20 | 447 | EC | US |
| PROG Holdings Inc | 74319R101 | $411K | 0.20 | 14322 | EC | US |
| Corvus Pharmaceuticals Inc | 221015100 | $411K | 0.20 | 28060 | EC | US |
| ORIC Pharmaceuticals Inc | 68622P109 | $410K | 0.20 | 32328 | EC | US |
| IDEXX Laboratories Inc | 45168D104 | $409K | 0.20 | 728 | EC | US |
| Omeros Corp | 682143102 | $406K | 0.19 | 38407 | EC | US |
| Sana Biotechnology Inc | 799566104 | $405K | 0.19 | 140705 | EC | US |
| Cullinan Therapeutics Inc | 230031106 | $400K | 0.19 | 28158 | EC | US |
| Stryker Corp | 863667101 | $400K | 0.19 | 1216 | EC | US |
| ResMed Inc | 761152107 | $394K | 0.19 | 1753 | EC | US |
| HCA Healthcare Inc | 40412C101 | $393K | 0.19 | 831 | EC | US |
| Hertz Global Holdings Inc | 42806J700 | $393K | 0.19 | 85261 | EC | US |
| Broadridge Financial Solutions | 11133T103 | $393K | 0.19 | 2419 | EC | US |
机构持有人 (13F) 5 家申报者
在其季度SEC表格13F中报告持有该ETF的机构。仅限多头头寸；单个申报者可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
| 机构 | 价值 | % 已追踪的13F | 股份 | 类型 | 截至 |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $816637 | 48.75% | 16412 | 股份 | 2026年6月30日 |
| CITADEL ADVISORS LLC | $584662 | 34.90% | 11750 | 股份 | 2026年6月30日 |
| JANE STREET GROUP, LLC | $226550 | 13.52% | 4553 | 股份 | 2026年6月30日 |
| UBS Group AG | $33288 | 1.99% | 669 | 股份 | 2026年6月30日 |
| Global Retirement Partners, LLC | $14181 | 0.85% | 285 | 股份 | 2026年6月30日 |
同类基金
规模相似
| 基金 | 资产管理规模 |
|---|---|
| SVAL iShares Trust | $209.4M |
| GDMN WisdomTree Trust | $209.5M |
| FBOT Fidelity Covington Trust | $211.2M |
| PGHY Invesco Exchange-Traded Fund ... | $211.5M |
| GINN Goldman Sachs ETF Trust | $212.6M |
| HSCZ iShares Trust | $208.4M |
| XTWY BondBloxx ETF Trust | $208.4M |
| PBD Invesco Exchange-Traded Fund ... | $208.4M |
| AVSE AMERICAN CENTURY ETF TRUST | $207.1M |
| XMPT VanEck ETF Trust | $205.8M |